Alterations of ubiquitylation and sumoylation in conventional renal cell carcinomas after the Chernobyl accident: a comparison with Spanish cases

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Virchows Archiv

• Publication date

  2011-07-23

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s00428-011-1124-8PMID 21786080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SUMO boosts the DNA damage response barrier against cancer.

  2010influential reference
• The ARF tumor suppressor: Structure, functions and status in cancer

  2010cited by this paper
• Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.

  2010cited by this paper
• The promiscuity of ARF interactions with the proteasome

  2008cited by this paper
• Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.

  2007cited by this paper
• Targeting mutant p53 shows promise for sunscreens and skin cancer.

  2007cited by this paper
• Role of the ubiquitin proteasome system in renal cell carcinoma

  2007cited by this paper
• Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation

  2007cited by this paper
• Ubiquitin COOH-Terminal Hydrolase 1: A Biomarker of Renal Cell Carcinoma Associated with Enhanced Tumor Cell Proliferation and Migration[?Q1: Running head: UCHL1, a Biomarker of RCC. Short title OK?Q1]

  2007cited by this paper
• Involvement of ubiquitination and sumoylation in bladder lesions induced by persistent long-term low dose ionizing radiation in humans.

  2006cited by this paper
• Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.

  2006cited by this paper
• Regulation of DNA repair by ubiquitylation

  2006cited by this paper
• The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease.

  2006cited by this paper
• The ubiquitin-proteasome pathway and its role in cancer.

  2005cited by this paper
• Modulation of p53 Degradation via MDM2-Mediated Ubiquitylation and the Ubiquitin–Proteasome System during Reperfusion after Stroke: Role of Oxidative Stress

  2005cited by this paper
• Sumoylation induced by the Arf tumor suppressor: a p53-independent function.

  2005cited by this paper
• World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs

  2005cited by this paper
• The role of the ubiquitin/proteasome system in cellular responses to radiation

  2003cited by this paper
• The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

  2002cited by this paper
• Ionizing radiation affects 26s proteasome function and associated molecular responses, even at low doses.

  2001cited by this paper
• Immunohistochemical [corrected] detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression.

  2001cited by this paper
• utImmunohistochemical Detection of the Alternate INK4a-Encoded Tumor Suppressor Protein p14ARF in Archival Human Cancers and Cell Lines Using Commercial Antibodies: Correlation with p16INK4a Expression

  2001cited by this paper
• Radiation sclerosing proliferative atypical nephropathy of peritumoral tissue of renal-cell carcinomas after the Chernobyl accident in Ukraine

  2001cited by this paper
• Pathology and proliferative activity of renal‐cell carcinomas (RCCS) and renal oncocytomas in patients with different radiation exposure after the Chernobyl accident in Ukraine

  2000cited by this paper
• The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells.

  1999cited by this paper
• The ubiquitin-proteasome proteolytic pathway.

  1994cited by this paper
• Multi-fractal nature of radioactivity deposition on soil after the Chernobyl accident.

  1991cited by this paper
• Prognostic significance of morphologic parameters in renal cell carcinoma

  1982cited by this paper

• Overdiagnosis and overtreatment of bladder and kidney lesions: Ethical and clinical lessons from past experience

  2025cites this paper
• Overestimation of medical consequences of low-dose exposures to ionizing radiation

  2022cites this paper
• Chernobyl consequences are coming

  2022cites this paper
• Chernobyl Cancer Studies with Overseas Control: High Grade vs. Late Detection

  2021influential citation
• Markers of Radiogenic Cancer vs. Tumor Progression: an Overview of Chernobyl Studies

  2021influential citation
• Jargin CHERNOBYL-RELATED CANCER AND PRECANCEROUS LESIONS : INCIDENCE INCREASE VS . LATE DIAGNOSTICS

  2018influential citation
• Deciphering the SUMO code in the kidney

  2018cites this paper
• Renal and hepatic effects following neonatal exposure to low doses of Bisphenol-A and 137Cs.

  2018cites this paper
• Environmental exposure to low‐doses of ionizing radiation. Effects on early nephrotoxicity in mice

  2017cites this paper
• Back to Chernobyl : Some Aspects of Cancer Diagnostics

  2016cites this paper
• Renal Cell Carcinoma after Chernobyl: on the Role of Radiation vs. Late Detection

  2015cites this paper
• Dose-response: an International Journal Chernobyl-related Cancer and Precancerous Lesions: Incidence Increase vs. Late Diagnostics Chernobyl-related Cancer and Precancerous Lesions: Incidence Increase vs. Late Diagnostics

  year unknowninfluential citation